Search form

Diagnostic and prognostic testing for Solid Tumours

The Bristol Genetics Laboratory offers an expanding repertoire of molecular and cytogenetic tests for a range of solid tumour types, useful for confirming diagnosis, assessing prognosis and for guiding therapeutic decisions. This stratified or personalised medicine approach is important in the treatment and management of patients with solid tumours. Our laboratory offers state-of-the-art clinical molecular testing for a range of clinically actionable genes in a variety of tumour types.